Bopharmaceutical Company, Biovac Opens New Facility to Manufacture African-Made Vaccines
AMA PRESS RELEASE Biovac, a South African biopharmaceutical company, is launching a state-of-the-art product development laboratory at its Cape Town facility, to expand the company’s ability to develop vaccines and other therapeutics. The new laboratory will strengthen Biovac’s world-class vaccine product development capabilities, enabling it to produce vaccines for Africa from the early stages of […]
Read More










